12 results
SC 13D/A
EX-2
CLS Therapeutics, LLC
18 Sep 23
Xenetic Biosciences / CLS Therapeutics ownership change
12:21pm
8-K
EX-2.1
XBIO
Xenetic Biosciences Inc
16 Jul 19
Entry into a Material Definitive Agreement
12:00am
8-K
EX-2.1
XBIO
Xenetic Biosciences Inc
24 Jun 19
Xenetic Biosciences, Inc. Announces Reverse Stock Split of Common Stock
5:16pm
8-K
EX-2.1
XBIO
Xenetic Biosciences Inc
13 Jun 19
Entry into a Material Definitive Agreement
5:12pm
425
EX-2.1
XBIO
Xenetic Biosciences Inc
13 Jun 19
Business combination disclosure
5:10pm
8-K/A
EX-2.1
51req1t1zz4kn
13 May 19
Other Events
9:10am
425
EX-2.1
4obphouzpr175pb
13 May 19
Business combination disclosure
9:08am
8-K
EX-2.1
dpqgd5j1jg1fafqnh
4 Mar 19
Entry into a Material Definitive Agreement
8:20am
8-K
EX-2.2
yr1j mrbltkqh
4 Mar 19
Entry into a Material Definitive Agreement
8:20am
425
EX-2.2
yhagqa5wm3b3kxfcmku
4 Mar 19
Business combination disclosure
8:18am
425
EX-2.1
iab7d3lf
4 Mar 19
Business combination disclosure
8:18am
8-K
EX-2.1
w302ligoearf61
29 Jan 14
Entry into a Material Definitive Agreement
12:00am
- Prev
- 1
- Next